Management of multiple valve disease.

Adrenergic beta-Antagonists/immunology/therapeutic use; Coronary Artery Bypass/methods; Echocardiography, Doppler; Heart Valve Diseases/diagnosis/etiology/surgery; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation/methods; Humans; Rheumatic Heart Disease

Abstract :

[en] Multivalvular heart disease is not an uncommon situation, but the paucity of data for each specific situation does not allow the proposal of a standardised, evidence-based management strategy. This paper aims at reviewing the available evidence on the management of multivalvular disease, taking into account the interactions between different valve lesions, the diagnostic pitfalls and the strategies that should be considered in the presence of multiple valvular disease.

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Unger, Philippe

Rosenhek, Raphael

Dedobbeleer, Chantal

Berrebi, Alain

LANCELLOTTI, Patrizio ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie

Language :

English

Title :

Management of multiple valve disease.

Publication date :

2011

Journal title :

Heart

ISSN :

1355-6037

eISSN :

1468-201X

Publisher :

BMJ Publishing Group, United Kingdom

Volume :

Issue :

Pages :

272-7

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 21 June 2013

Statistics

Number of views

62 (2 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Vahanian A, Baumgartner H, Bax J, et al. Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-68.
Bonow RO, Carabello BA, Chatterjee K, et al. American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008;52:e1-142.
Jamieson WR, Edwards FH, Schwartz M, et al. Risk stratification for cardiac valve replacement. National Cardiac Surgery Database. Database Committee of The Society of Thoracic Surgeons. Ann Thorac Surg 1999;67:943-51.
Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-43.
Soma Raju B, Turi ZG. Rheumatic fever. In: Braunwald's Heart Disease. A textbook of Cardiovascular Medicine. 8th edn. Saunders Elsevier, Philadelphia, USA 2008:2079-103.
Roberts WC, Dangel JC, Bulkley BH. Nonrheumatic valvular cardiac disease: a clinico-pathologic survey of 27 different conditions causing valvular dysfunction. Cardiovasc Clin 1973;5:333-446.
Carlson RG, Mayfield WR, Normann S, et al. Radiation-associated valvular disease. Chest 1991;99:538-45.
Mihaljevic T, Byrne JG, Cohn LH, et al. Long-term results of multivalve surgery for infective multivalve endocarditis. Eur J Cardiothorac Surg 2001;20:842-6.
Horvath J, Fross RD, Kleiner-Fisman G, et al. Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists. Mov Disord 2004;19:656-62.
Erek E, Casselman FR, Vanermen H. Cardiac ochronosis: valvular heart disease with dark green discoloration of the leaflets. Tex Heart Inst J 2004;31:445-7.
Matsuoka R, Misugi K, Goto A, et al. Congenital heart anomalies in the trisomy 18 syndrome, with reference to congenital polyvalvular disease. Am J Med Genet 1983;14:657-68.
Kowal-Vern A, Bharati S, Melnyk A, et al. Congenital polyvalvular cardiac disease without chromosomal abnormalities. Pediatr Pathol Lab Med 1995;15:299-308.
Brauner RA, Laks H, Drinkwater DC Jr, et al. Multiple left heart obstructions (Shone's anomaly) with mitral valve involvement: long-term surgical outcome. Ann Thorac Surg 1997;64:721-9.
Aronow WS. Heart disease and aging. Med Clin North Am 2006;90:849-62.
Bhattacharyya S, Gujral DM, Toumpanakis C, et al. A stepwise approach to the management of metastatic midgut carcinoid tumor. Nat Rev Clin Oncol 2009;6:429-33.
Balik M, Pachl J, Hendl J. Effect of the degree of tricuspid regurgitation on cardiac output measurements by thermodilution. Intensive Care Med 2002;28:1117-21.
Alsoufi B, Rao V, Borger MA, et al. Short- and long-term results of triple valve surgery in the modern era. Ann Thorac Surg 2006;81:2172-8.
Mueller XM, Tevaearai HT, Ruchat P, et al. Perioperative morbidity and mortality in combined aortic and mitral valve surgery. J Heart Valve Dis 1997;6:387-94.
Society of Thoracic Surgeon Adult Cardiovascular Surgery Database, 2005. http://sts. org/documents/pdf/Spring2005STS-ExecutiveSummary.pdf.
Mueller XM, Tevaearai HT, Stumpe F, et al. Long-term results of mitral-aortic valve operations. J Thorac Cardiovasc Surg 1998;115:1298-302.
Turina J, Stark T, Seifert B, et al. Predictors of the long-term outcome after combined aortic and mitral valve surgery. Circulation 1999;100(Suppl 19):II48-53.
Unger P, Dedobbeleer C, Van Camp G, et al. Mitral regurgitation in patients with aortic stenosis undergoing valve replacement. Heart 2010;96:9-14.
Connolly HM, Oh JK, Orszulak TA, et al. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction: prognostic indicators. Circulation 1997;95:2395-400.
Unger P, Magne J, Vanden Eynden F, et al. Impact of prosthesis-patient mismatch on mitral regurgitation after aortic valve replacement. Heart 2010;96:1627-32.
Unger P, Plein D, Van Camp G, et al. Effects of valve replacement for aortic stenosis on mitral regurgitation. Am J Cardiol 2008;102:1378-82.
Gillinov AM, Blackstone EH, Cosgrove DM 3rd, et al. Mitral valve repair with aortic valve replacement is superior to double valve replacement. J Thorac Cardiovasc Surg 2003;125:1372-87.
Smith WT, Ferguson TB Jr, Ryan T, et al. Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma. J Am Coll Cardiol 2004;44:1241-7.
Pereira JJ, Balaban K, Lauer MS, et al. Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery. Am J Med 2005;118:735-42.
Gillinov AM, Garcia MJ. When is concomitant aortic valve replacement indicated in patients with mild to moderate stenosis undergoing coronary revascularization? Curr Cardiol Rep 2005;7:101-4.
Sareyyupoglu B, Sundt TM 3rd, Schaff HV, et al. Management of mild aortic stenosis at the time of coronary artery bypass surgery: should the valve be replaced? Ann Thorac Surg 2009;88:1224-31.
Niles N, Borer JS, Kamen M, et al. Preoperative left and right ventricular performance in combined aortic and mitral regurgitation and comparison with isolated aortic or mitral regurgitation. Am J Cardiol 1990;65:1372-8. (Pubitemid 20172507)
Zitnik RS, Piemme TE, Messer RJ, et al. the masking of aortic stenosis by mitral stenosis. Am Heart J 1965;69:22-30.
Segal J, Harvey WP, Hufnagel C. A clinical study of one hundred cases of severe aortic insufficiency. Am J Med 1956;21:200-10.
Cohn LH, Mason DT, Ross J Jr, et al. Preoperative assessment of aortic regurgitation in patients with mitral valve disease. Am J Cardiol.1967;19:177- 82.
Nakatani S, Masuyama T, Kodama K, et al. Value and limitations of Doppler echocardiography in the quantification of stenotic mitral valve area: comparison of the pressure half-time and the continuity equation methods. Circulation 1988;77:78-85.
Flachskampf FA, Weyman AE, Gillam L, et al. Aortic regurgitation shortens Doppler pressure half-time in mitral stenosis: clinical evidence, in vitro simulation and theoretic analysis. J Am Coll Cardiol 1990;2:396-404.
Gash AK, Carabello BA, Kent RL, et al. Left ventricular performance in patients with coexistent mitral stenosis and aortic insufficiency. J Am Coll Cardiol 1984;3:703-11.
Enriquez-Sarano M, Tajik AJ. Aortic regurgitation. N Engl J Med 2004;351:1539-46.
Sampat U, Varadarajan P, Turk R, et al. Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. J Am Coll Cardiol 2009;54:452-7.
Chen CR, Cheng TO, Chen JY, et al. Percutaneous balloon mitral valvuloplasty for mitral stenosis with and without associated aortic regurgitation. Am Heart J 1993;125:128-37.
Cohn LH. Tricuspid regurgitation secondary to mitral valve disease: when and how to repair. J Card Surg 1994;9:237-41.
Colombo T, Russo C, Ciliberto GR, et al. Tricuspid regurgitation secondary to mitral valve disease: tricuspid annulus function as guide to tricuspid valve repair. Cardiovasc Surg 2001;9:369-77.
Dreyfus GD, Corbi PJ, Chan KM, et al. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg 2005;79:127-32.
Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004;43:405-9.
Skudicky D, Essop MR, Sareli P. Efficacy of mitral balloon valvotomy in reducing the severity of associated tricuspid valve regurgitation. Am J Cardiol 1994;73:209-11. (Pubitemid 24037787)
Bhattacharyya S, Davar J, Dreyfus G, et al. Carcinoid heart disease. Circulation 2007;116:2860-5.